VANCOUVER, Aug. 17, 2015 - Eyecarrot Innovations Corp ($EYC:CA) is pleased to announce the appointment of Todd Finch as Head of the Eyecarrot Advisory Board.
Todd Finch is a technology leader with over 25 years of industry experience, building innovative high growth businesses. Todd has led a number of high growth technology companies. He supports Founders and CEOs through his advisory and syndicated investment fund. In addition, Todd advises the MaRS Discovery District as a passionate advocate to the ongoing development of start-ups, and the Canadian entrepreneurial ecosystem.
As an early stage CEO, Todd led a number of start-up companies raising over $75M in venture capital. He served as the President & CEO of Vizible Corporation (acquired by OpenText in 2009), a company recognized as one of the fastest growing, most innovative companies in Canada by Deloitte's Fast 50. As Founder and President of Netscape Canada, Todd helped in leading the initial commercialization phase of the Internet. Prior to Netscape, Todd was a co-founder of Visible Decisions (Acquired by Lucent in 1995). Todd holds a bachelors degree from Wilfrid Laurier University and currently sits on the Dean's Advisory Council for Science. He is a founding board member of The Smilezone Foundation, a charity that transforms living spaces in facilities that help children in need.
"A proven leader in the technology landscape and a pioneering visionary in the evolution of the internet. Eyecarrot is incredibly fortunate to have secured the services of another world class executive to lead the growth of the company. The modern healthcare revolution to impact the lives of billions of humans will be achieved through the convergence of healthcare and technology. The appointments of Dr. Norton and Mr Finch solidify Eyecarrot's foundation in both of these areas." Commented Adam Cegielski, Founder of Eyecarrot
Eyecarrot is Engineering Vision Science through Innovation and Big Data. We are building the BinoviTM Cloud, a universal system for testing and measuring a human's Oculomotor Sensory System performance.
On behalf of the Board of Directors
Founder | CPO
Telephone: 1.855.416.7158 - 416.943.6271
Forward looking information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer